Protein Therapeutics

PreEMT is a patented technology for the disaggregation and controlled refolding of proteins with high fidelity of native structure at yields and efficiencies not always achievable using existing technologies. PreEMT is applicable to a wide variety of therapeutic proteins (existing or novel) including single polypeptide chains, multimeric protein complexes with and without disulfide bridges, and protein crystals. PreEMT can be utilized in the refolding of recombinant proteins produced in mammalian cells, yeast or E. coli.


Pressure BioSciences Announces Acquisition of All Assets of BaroFold, Inc.


BaroFold Awarded Patent for Using High Pressure to Improve the Safety Profile of Biologic Drugs


Lonza to Evaluate BaroFold’s Protein Refolding Technology


Boehringer Ingelheim and BaroFold Announce Strategic Agreement on PreEMT™ High Pressure Protein Refolding Technology

more >>

BaroFold, Inc.
12635 E. Montview Blvd
Aurora, CO 80045